Lumos Diagnostics' market value is the price at which a share of Lumos Diagnostics trades on a public exchange. It measures the collective expectations of Lumos Diagnostics Holdings investors about its performance. Lumos Diagnostics is trading at 0.19 as of the 27th of December 2025. This is a 5.56 percent increase since the beginning of the trading day. The stock's lowest day price was 0.19. With this module, you can estimate the performance of a buy and hold strategy of Lumos Diagnostics Holdings and determine expected loss or profit from investing in Lumos Diagnostics over a given investment horizon. Check out Lumos Diagnostics Correlation, Lumos Diagnostics Volatility and Lumos Diagnostics Alpha and Beta module to complement your research on Lumos Diagnostics.
Please note, there is a significant difference between Lumos Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lumos Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lumos Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lumos Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lumos Diagnostics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lumos Diagnostics.
0.00
11/27/2025
No Change 0.00
0.0
In 31 days
12/27/2025
0.00
If you would invest 0.00 in Lumos Diagnostics on November 27, 2025 and sell it all today you would earn a total of 0.00 from holding Lumos Diagnostics Holdings or generate 0.0% return on investment in Lumos Diagnostics over 30 days. Lumos Diagnostics is related to or competes with BioPorto A/S, Shield Therapeutics, Orexo AB, Starpharma Holdings, VITA 34, Paradigm Biopharmaceutica, and Senzime AB. Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point... More
Lumos Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lumos Diagnostics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lumos Diagnostics Holdings upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lumos Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lumos Diagnostics' standard deviation. In reality, there are many statistical measures that can use Lumos Diagnostics historical prices to predict the future Lumos Diagnostics' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lumos Diagnostics. Your research has to be compared to or analyzed against Lumos Diagnostics' peers to derive any actionable benefits. When done correctly, Lumos Diagnostics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Lumos Diagnostics.
Lumos Diagnostics Backtested Returns
Lumos Diagnostics is out of control given 3 months investment horizon. Lumos Diagnostics has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12 % return per unit of risk over the last 3 months. We have analyze and collected data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.73% are justified by taking the suggested risk. Use Lumos Diagnostics Mean Deviation of 9.54, risk adjusted performance of 0.0925, and Downside Deviation of 17.08 to evaluate company specific risk that cannot be diversified away. Lumos Diagnostics holds a performance score of 9 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 1.74, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lumos Diagnostics will likely underperform. Use Lumos Diagnostics sortino ratio and the relationship between the potential upside and day median price , to analyze future returns on Lumos Diagnostics.
Auto-correlation
0.66
Good predictability
Lumos Diagnostics Holdings has good predictability. Overlapping area represents the amount of predictability between Lumos Diagnostics time series from 27th of November 2025 to 12th of December 2025 and 12th of December 2025 to 27th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lumos Diagnostics price movement. The serial correlation of 0.66 indicates that around 66.0% of current Lumos Diagnostics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.66
Spearman Rank Test
0.4
Residual Average
0.0
Price Variance
0.0
Lumos Diagnostics lagged returns against current returns
Autocorrelation, which is Lumos Diagnostics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lumos Diagnostics' pink sheet expected returns. We can calculate the autocorrelation of Lumos Diagnostics returns to help us make a trade decision. For example, suppose you find that Lumos Diagnostics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Lumos Diagnostics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lumos Diagnostics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lumos Diagnostics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lumos Diagnostics pink sheet over time.
Current vs Lagged Prices
Timeline
Lumos Diagnostics Lagged Returns
When evaluating Lumos Diagnostics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lumos Diagnostics pink sheet have on its future price. Lumos Diagnostics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lumos Diagnostics autocorrelation shows the relationship between Lumos Diagnostics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Lumos Diagnostics Holdings.
Other Information on Investing in Lumos Pink Sheet
Lumos Diagnostics financial ratios help investors to determine whether Lumos Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lumos with respect to the benefits of owning Lumos Diagnostics security.